FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361960796> ?p ?o ?g. }

• W4361960796 abstract "<div>Abstract<p><b>Purpose:</b> Ad5.SSTR/TK.RGD is an infectivity-enhanced adenovirus expressing a therapeutic thymidine kinase suicide gene and a somatostatin receptor (SSTR) that allows for noninvasive gene transfer imaging. The purpose of this study was to identify the maximum tolerated dose (MTD), toxicities, clinical efficacy, and biologic effects of Ad5.SSTR/TK.RGD in patients with recurrent gynecologic cancer.</p><p><b>Experimental Design:</b> Eligible patients were treated intraperitoneally for 3 days with 1 × 10⁹ to 1 × 10¹² vp/dose of Ad5.SSTR/TK.RGD followed by intravenous ganciclovir for 14 days. Toxicity and clinical efficacy were assessed using Common Toxicity Criteria (CTC) Adverse Events grading and Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Imaging using In-111 pentetreotide was obtained before and after treatment. Tissue samples were obtained to evaluate for gene transfer, generation of wild-type virus, viral shedding, and antibody response.</p><p><b>Results:</b> Twelve patients were treated in three cohorts. The most common vector-related clinical toxicities were grade I/II constitutional or pain symptoms, experienced most often in patients treated at the highest dose. MTD was not identified. Five patients showed stable disease; all others experienced progressive disease. One patient with stable disease experienced complete resolution of disease and normalization of CA125 on further follow-up. Imaging detected increased In-111 pentetreotide retention in patients treated at the highest dose. Ancillary studies showed presence of Ad5.SSTR/TK.RGD virus and <i>HSV1-tk</i> expression in ascites samples collected at various time points in most patients treated within the higher dose cohorts.</p><p><b>Conclusions:</b> This study shows the safety, potential efficacy, and possible gene transfer imaging capacity of Ad5.SSTR/TK.RGD in patients with recurrent gynecologic cancer. Further development of this novel gene therapeutic appears to be warranted. <i>Clin Cancer Res; 18(12); 3440–51. ©2012 AACR</i>.</p></div>" @default.
• W4361960796 created "2023-04-05" @default.
• W4361960796 creator A5009816072 @default.
• W4361960796 creator A5017208495 @default.
• W4361960796 creator A5019160700 @default.
• W4361960796 creator A5022987623 @default.
• W4361960796 creator A5035886150 @default.
• W4361960796 creator A5036159485 @default.
• W4361960796 creator A5036647389 @default.
• W4361960796 creator A5040167645 @default.
• W4361960796 creator A5044981711 @default.
• W4361960796 creator A5069881830 @default.
• W4361960796 creator A5070929898 @default.
• W4361960796 creator A5079520757 @default.
• W4361960796 creator A5083849374 @default.
• W4361960796 date "2023-03-31" @default.
• W4361960796 modified "2023-10-14" @default.
• W4361960796 title "Data from A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer" @default.
• W4361960796 doi "https://doi.org/10.1158/1078-0432.c.6520214" @default.
• W4361960796 hasPublicationYear "2023" @default.
• W4361960796 type Work @default.
• W4361960796 citedByCount "0" @default.
• W4361960796 crossrefType "posted-content" @default.
• W4361960796 hasAuthorship W4361960796A5009816072 @default.
• W4361960796 hasAuthorship W4361960796A5017208495 @default.
• W4361960796 hasAuthorship W4361960796A5019160700 @default.
• W4361960796 hasAuthorship W4361960796A5022987623 @default.
• W4361960796 hasAuthorship W4361960796A5035886150 @default.
• W4361960796 hasAuthorship W4361960796A5036159485 @default.
• W4361960796 hasAuthorship W4361960796A5036647389 @default.
• W4361960796 hasAuthorship W4361960796A5040167645 @default.
• W4361960796 hasAuthorship W4361960796A5044981711 @default.
• W4361960796 hasAuthorship W4361960796A5069881830 @default.
• W4361960796 hasAuthorship W4361960796A5070929898 @default.
• W4361960796 hasAuthorship W4361960796A5079520757 @default.
• W4361960796 hasAuthorship W4361960796A5083849374 @default.
• W4361960796 hasBestOaLocation W43619607962 @default.
• W4361960796 hasConcept C126322002 @default.
• W4361960796 hasConcept C143998085 @default.
• W4361960796 hasConcept C197934379 @default.
• W4361960796 hasConcept C203014093 @default.
• W4361960796 hasConcept C2522874641 @default.
• W4361960796 hasConcept C2777965375 @default.
• W4361960796 hasConcept C2779820661 @default.
• W4361960796 hasConcept C2779984678 @default.
• W4361960796 hasConcept C29730261 @default.
• W4361960796 hasConcept C31760486 @default.
• W4361960796 hasConcept C71924100 @default.
• W4361960796 hasConcept C90924648 @default.
• W4361960796 hasConceptScore W4361960796C126322002 @default.
• W4361960796 hasConceptScore W4361960796C143998085 @default.
• W4361960796 hasConceptScore W4361960796C197934379 @default.
• W4361960796 hasConceptScore W4361960796C203014093 @default.
• W4361960796 hasConceptScore W4361960796C2522874641 @default.
• W4361960796 hasConceptScore W4361960796C2777965375 @default.
• W4361960796 hasConceptScore W4361960796C2779820661 @default.
• W4361960796 hasConceptScore W4361960796C2779984678 @default.
• W4361960796 hasConceptScore W4361960796C29730261 @default.
• W4361960796 hasConceptScore W4361960796C31760486 @default.
• W4361960796 hasConceptScore W4361960796C71924100 @default.
• W4361960796 hasConceptScore W4361960796C90924648 @default.
• W4361960796 hasLocation W43619607961 @default.
• W4361960796 hasLocation W43619607962 @default.
• W4361960796 hasOpenAccess W4361960796 @default.
• W4361960796 hasPrimaryLocation W43619607961 @default.
• W4361960796 hasRelatedWork W2356374822 @default.
• W4361960796 hasRelatedWork W2406666623 @default.
• W4361960796 hasRelatedWork W2917681345 @default.
• W4361960796 hasRelatedWork W2936810997 @default.
• W4361960796 hasRelatedWork W2996891337 @default.
• W4361960796 hasRelatedWork W3102005587 @default.
• W4361960796 hasRelatedWork W3137800304 @default.
• W4361960796 hasRelatedWork W3197516152 @default.
• W4361960796 hasRelatedWork W4225264031 @default.
• W4361960796 hasRelatedWork W4295226633 @default.
• W4361960796 isParatext "false" @default.
• W4361960796 isRetracted "false" @default.
• W4361960796 workType "article" @default.